CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: gabapentin
Accession: CHEBI:42797
browse the term
Definition: A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Synonyms: exact_synonym: [1-(aminomethyl)cyclohexyl]acetic acid
related_synonym: 1-(Aminomethyl)cyclohexaneacetic acid; Formula=C9H17NO2; InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12); InChIKey=UGJMXCAKCUNAIE-UHFFFAOYSA-N; Neurontin; SMILES=NCC1(CCCCC1)CC(O)=O; gabapentina; gabapentine; gabapentinum
alt_id: CHEBI:5237
xref: Beilstein:2359739; CAS:60142-96-3; DrugBank:DB00996; Drug_Central:1264; HMDB:HMDB0005015; KEGG:D00332; LINCS:LSM-5716
xref_mesh: MESH:C040029
xref: PDBeChem:GBN; PMID:22048285; PMID:22144034; PMID:22240839; PMID:22240859; PMID:22279347; PMID:22296650; PMID:22345405; PMID:22352861; PMID:22419014; PMID:22422817; PMID:22464746; PMID:22467888; PMID:22556282; PMID:22575516; PMID:22612015; PMID:22865488; PMID:22888801; PMID:22934077; PMID:22946876; PMID:23018586; PMID:23053645; Patent:EP1140793; Patent:US2008103334; Patent:US2008269326; Patent:US2009043126; Patent:US2009292138; Patent:US2012046272; Patent:WO2005037784; Patent:WO2008060572; Patent:WO2010023694; Reaxys:2359739; VSDB:2975; Wikipedia:Gabapentin
G
Aadat
aminoadipate aminotransferase
decreases activity
EXP
gabapentin results in decreased activity of AADAT protein
CTD
PMID:16765940
NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases activity
ISO
gabapentin results in decreased activity of ABCB1 protein
CTD
PMID:18408562
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Akr7a3
aldo-keto reductase family 7 member A3
increases expression
EXP
gabapentin results in increased expression of AKR7A3 mRNA
CTD
PMID:17381134
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
decreases activity multiple interactions
EXP ISO
gabapentin results in decreased activity of CACNA1A protein gabapentin promotes the reaction [[omega-Agatoxin IVA results in decreased activity of CACNA1A protein] which results in decreased susceptibility to Potassium Chloride]
CTD
PMID:12770949 PMID:12817894
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
decreases activity
EXP
gabapentin results in decreased activity of CACNA1B protein
CTD
PMID:12770949
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
multiple interactions
EXP
CACNA2D1 protein results in increased susceptibility to [gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]]; gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]; gabapentin affects the reaction [[CACNA1D protein co-treated with CACNB3 protein] results in increased transport of Calcium]
CTD
PMID:19796812
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Cacna2d1
calcium voltage-gated channel auxiliary subunit alpha2delta 1
multiple interactions affects binding
ISO EXP
[gabapentin binds to and results in decreased activity of CACNA2D1 protein] which results in decreased susceptibility to Methamphetamine; [gabapentin binds to and results in decreased activity of CACNA2D1 protein] which results in decreased susceptibility to Potassium Chloride; [gabapentin results in decreased activity of CACNA2D1 protein] inhibits the reaction [Potassium Chloride results in increased transport of Calcium]; gabapentin inhibits the reaction [Methamphetamine results in increased expression of CACNA2D1 mRNA] gabapentin binds to CACNA2D1 protein CACNA2D1 protein results in increased susceptibility to [gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]]
CTD
PMID:16380257 PMID:17442347 PMID:17881535 PMID:19796812 PMID:20340177 PMID:21182903 More...
NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969
G
Cacna2d2
calcium voltage-gated channel auxiliary subunit alpha2delta 2
affects activity affects binding
ISO
CACNA2D2 protein affects the activity of gabapentin gabapentin binds to CACNA2D2 protein
CTD
PMID:11687876 PMID:14660671
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
G
Cacnb3
calcium voltage-gated channel auxiliary subunit beta 3
multiple interactions
EXP
CACNA2D1 protein results in increased susceptibility to [gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]]; gabapentin affects the activity of [CACNA1D protein co-treated with CACNB3 protein]; gabapentin affects the reaction [[CACNA1D protein co-treated with CACNB3 protein] results in increased transport of Calcium]
CTD
PMID:19796812
NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074
G
Cp
ceruloplasmin
decreases expression
EXP
gabapentin results in decreased expression of CP mRNA
CTD
PMID:17381134
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
EXP
gabapentin results in decreased expression of CYP1A1 mRNA
CTD
PMID:17381134
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
EXP
gabapentin results in decreased expression of CYP2E1 mRNA
CTD
PMID:17381134
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
decreases expression
EXP
Gabapentin results in decreased expression of CYP3A23-3A1 mRNA
CTD
PMID:17381134
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
decreases expression
EXP
gabapentin results in decreased expression of CYP4A1 mRNA
CTD
PMID:17381134
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
G
Dlg4
discs large MAGUK scaffold protein 4
multiple interactions
ISO
Gabapentin inhibits the reaction [monobutyl phthalate results in increased expression of DLG4 protein]
CTD
PMID:35278568
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
G
F10
coagulation factor X
decreases expression
EXP
gabapentin results in decreased expression of F10 mRNA
CTD
PMID:17381134
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
Gabapentin results in decreased expression of G6PC1 mRNA
CTD
PMID:17381134
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gabbr1
gamma-aminobutyric acid type B receptor subunit 1
multiple interactions
ISO
CGP 71872 inhibits the reaction [gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]]; gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]
CTD
PMID:11125035
NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
multiple interactions
ISO
CGP 71872 inhibits the reaction [Gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]]; Gabapentin binds to and results in increased activity of [GABBR1 protein alternative form binds to GABBR2 protein]
CTD
PMID:11125035
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
ISO
Gabapentin results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Gsta2
glutathione S-transferase alpha 2
decreases expression
EXP
gabapentin results in decreased expression of GSTA2 mRNA
CTD
PMID:17381134
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gstm1
glutathione S-transferase mu 1
increases expression
EXP
gabapentin results in increased expression of GSTM1 mRNA
CTD
PMID:17381134
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Hmox1
heme oxygenase 1
increases expression
EXP
gabapentin results in increased expression of HMOX1 mRNA
CTD
PMID:17381134
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases expression
EXP
gabapentin results in decreased expression of HSP90AA1 mRNA
CTD
PMID:17381134
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Igf1
insulin-like growth factor 1
increases expression
EXP
gabapentin results in increased expression of IGF1 mRNA
CTD
PMID:17381134
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
decreases activity
ISO
gabapentin results in decreased activity of KCNH2 protein
CTD
PMID:15716081
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Kyat1
kynurenine aminotransferase 1
decreases activity
EXP
gabapentin results in decreased activity of KYAT1 protein
CTD
PMID:16765940
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
G
Lpo
lactoperoxidase
decreases expression
ISO
Gabapentin results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
Gabapentin results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Ncl
nucleolin
increases expression
EXP
gabapentin results in increased expression of NCL mRNA
CTD
PMID:17381134
NCBI chr 9:86,999,588...87,008,112
Ensembl chr 9:86,998,019...87,008,136
G
Nos2
nitric oxide synthase 2
increases expression
EXP
gabapentin results in increased expression of NOS2 protein
CTD
PMID:14511393
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
gabapentin results in increased expression of NQO1 mRNA
CTD
PMID:17381134
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Pnoc
prepronociceptin
decreases expression
ISO
gabapentin results in decreased expression of PNOC mRNA
CTD
PMID:18281898
NCBI chr15:39,624,635...39,652,463
Ensembl chr15:39,624,641...39,651,867
G
Pon1
paraoxonase 1
decreases activity
ISO
gabapentin results in decreased activity of PON1 protein
CTD
PMID:28032682
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Gabapentin results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
G
Slc22a7
solute carrier family 22 member 7
increases expression decreases expression
EXP
gabapentin results in increased expression of SLC22A7 mRNA gabapentin results in decreased expression of SLC22A7 mRNA
CTD
PMID:17381134
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc6a4
solute carrier family 6 member 4
decreases expression
ISO
Gabapentin results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Slc7a5
solute carrier family 7 member 5
increases import
ISO
SLC7A5 protein results in increased import of gabapentin
CTD
PMID:27818298
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
St13
ST13, Hsp70 interacting protein
increases expression
EXP
gabapentin results in increased expression of ST13 mRNA
CTD
PMID:17381134
NCBI chr 7:112,891,007...112,925,727
Ensembl chr 7:112,844,375...112,925,945
G
Sult1a1
sulfotransferase family 1A member 1
decreases expression
EXP
gabapentin results in decreased expression of SULT1A1 mRNA
CTD
PMID:17381134
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Syn1
synapsin I
multiple interactions
ISO
Gabapentin inhibits the reaction [monobutyl phthalate results in increased expression of SYN1 protein]
CTD
PMID:35278568
NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396
G
Tac1
tachykinin, precursor 1
multiple interactions
EXP
gabapentin inhibits the reaction [Freund's Adjuvant promotes the reaction [Capsaicin results in increased secretion of TAC1 protein]]
CTD
PMID:14499429
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tkt
transketolase
increases expression
EXP
gabapentin results in increased expression of TKT mRNA
CTD
PMID:17381134
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Txnrd1
thioredoxin reductase 1
increases expression
EXP
gabapentin results in increased expression of TXNRD1 mRNA
CTD
PMID:17381134
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ugdh
UDP-glucose 6-dehydrogenase
decreases expression
EXP
gabapentin results in decreased expression of UGDH mRNA
CTD
PMID:17381134
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
EXP
gabapentin results in increased expression of UGT2B1 mRNA
CTD
PMID:17381134
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all